[Marihuana and cannobinoids as medicaments]. [Przegl Lek. 2012] - PubMed - NCBI

Przegl Lek. 2012;69(10):1095-7. [Marihuana and cannobinoids as medicaments].

[Article in Polish]

Tkaczyk M, Florek E, Piekoszewski W.

Source Krakowska Wyzsza Szkoła Promocji Zdrowia, Kraków.

Abstract

Biological activity of cannabinoids is caused by binding to two cannabinoid receptors CB1 and CB2. Psychoactive is not only tetrahydrocannabinol (THC) but also: cannabidiol, cannabigerol or cannabichromen. Formerly, the usefulness of hemp was assessed in the relation to temporary appeasement of the symptoms of some ailments as nausea or vomiting. Present discoveries indicates that cannabis-based drugs has shown ability to alleviate of autoimmunological disorders such as: Multiple sclerosis (MS), Rheumatoid arthritis (RA) or inflammatory bowel disease. Another studies indicates that cannabinoids play role in treatment of neurological disorders like Alzheimer disease or Amyotrophic lateral sclerosis (ALS) or even can reduce spreading of tumor cells. Cannabinoids stand out high safety profile considering acute toxicity, it is low possibility of deadly overdosing and side-effects are comprise in range of tolerated side-effects of other medications.

via [Marihuana and cannobinoids as medicaments]. [Przegl Lek. 2012] - PubMed - NCBI.